Andrew Desio, PharmD BCPS BCCP BCCCP BCIDP
@PharmDFarmD
Followers
737
Following
7K
Media
76
Statuses
2K
Super Saiyan of Pharmacy
Chicago, IL
Joined February 2022
Some say that early lantus is the phenobarbital of DKA
1
1
39
Come work with a fantastic group of ID pharmacists! Lots of exciting ID projects to do and patients to care for!
🚨🚨Excited to share our BRAND NEW PGY-2 Infectious Diseases Residency Program @ Loyola University Medical Center (Maywood, IL) 🚨🚨 Learn more about the program by registering for our open house on Nov 26th (6-7 PM CST) Link: https://t.co/N6QwFDzbXh
0
1
9
And we’re off! See y’all on the other side!
1
0
6
🔥🔥Just published🔥🔥 Our NEW @Wiki_Guidelines @JAMANetworkOpen A stellar cast of auth🌟rs @zacroBID @amenalor @BradSpellberg @DrToddLee @DrEmilyMcD Guidelines for the Prevention Diagnosis,and Management of Urinary Tract Infections in Pediatrics& Adults https://t.co/zakvuleqpU
7
121
278
We are delighted to announce the publication of UTI WikiGuideline in JAMA Network Open. Thank you to the 54 experts from 12 countries for drafting. Special thanks to @zacroBID and @amenalor for leading the effort. https://t.co/XC2MgtjTdb
0
0
1
Filed under “duh” but it’s the thing that gets done every time. I’m all for ensuring there isn’t some component of vitamin K deficiency but the repeated daily (or more frequent!) dosing blows my mind
Vitamin K doesn’t improve INR or reduce bleeding in people hospitalized with cirrhosis https://t.co/sMVrHg1rrf.
0
0
11
Great presentation on this a few years ago at C4 conference. I think about this most days in the ICU.
A pharmacist’s guide to mitigating sleep dysfunction and promoting good sleep in the intensive care unit:
0
0
1
Maybe more valuable to ask what the rush to obtain access when compressions and rhythm check/shocking are so much more valuable. Considering the results of PARAMEDIC-2, would have hoped for a different approach in this trial.
In the PARAMEDIC-3 trial involving adults with out-of-hospital cardiac arrest, an intraosseous-first strategy for vascular access did not result in a higher incidence of 30-day survival than an intravenous-first strategy. Full trial results: https://t.co/JaFt5ad8nO
#RESUS24
0
0
5
This one has me scratching my head a bit. What’s the mechanism here?
5/ #kidneywk 💊acetaminophen is not that benign either This cross over RCT showed it can increase BP See #Nephjc visual abstract by @Husamjz and summary by @Momen_Abbasi
https://t.co/UaYgxx8HUU
0
0
1
Dang! Would not have guessed that!
3/ #nephjc visual abstract spotted 😱Opioid use is associated with greater harm in CKD than NSAIDs with a substantial increase in risk for death and poor kidney outcomes. #kidneywk
https://t.co/n6aRrM9iju.
0
0
0
Oral water more effective than IV water for immediate BP rise in orthostatic hypotension. Oropharyngeal SNS receptors to the rescue. Super cool. #KidneyWk
11
176
887
Uhhhhh
Dr. Kopack from FDA also discussed trial 302, which tested sulopenem in people with complicated UTI, and it was inferior to ciprofloxacin, as were the results in trial 303 for complicated intraabdominal infections. Therefore, sulopenem should only be used in uUTI. 😲
0
0
1
Thanks to @ABsteward for finding the latest Shorter Is Better study! No, not BALANCE. That ain't published yet. Rather, it's the 57th short course periop prophylaxis RCT. Yes, you heard right. 57. So...how many do you need? Kinda getting embarrassing no? https://t.co/1oaAT6Cybb
7
53
225
1% MRSA and 1% pseudomonas? Could have fooled me with the empiric coverage 😢
1/2 Dr. Shruti Gohil @UCIrvineHealth presented INSPIRE data on intra-abdominal infections (IAIs) at #IDWeek2024. IAIs involve diverse organs/spaces. Yet, only 1% (+) for MRSA and another 1% (+) for Pseudomonas, despite 63% of patients getting empiric broad-spectrum abx treatment.
0
4
25
So curious if anyone attended this and could share slides or some insight!
1
0
1
🔥BALANCE RCT🔥 results #IDWeek2024 3,608 patients 74 hospitals in 7 countries A 7-day course of antibiotics for hospitalized patients with bloodstream infections is just as effective as a 14-day course,Both treatment durations demonstrated similar 90d mortality & relapse rates.
https://t.co/NyGY7egdW9
@ABsteward @DrEmilyMcD @BradSpellberg Balance results will be presented Friday at ID week. 7 days NI to 14 for most uncomplicated bacteremia (powered on *mortality*)
5
27
119
https://t.co/NyGY7egdW9
@ABsteward @DrEmilyMcD @BradSpellberg Balance results will be presented Friday at ID week. 7 days NI to 14 for most uncomplicated bacteremia (powered on *mortality*)
idsociety.org
8
41
145
I love these two slides on the evidence for combination therapy in persistent MRSA and MSSA bacteremia. References in footer of each slide. #IDWeek2024
5
147
459
Ever been frustrated by the excuse, “Sorry, it’s against hospital policy” when you needed to do something important to help someone? Well, we solved that. Get your hospital to adopt the Policy to Override Policies! https://t.co/4jBLuItmLE
jamanetwork.com
This Viewpoint describes allowing for hospital staff discretion regarding strict adherence to policy vs best interest of the patient.
10
37
164